The trading volumes on the counter surged over five-fold with a combined 2.51 million shares representing 17% of total equity of the company changed hands till 1205 hours on NSE and BSE.
In past three trading sessions, the stock rallied 51% from Rs 300 on November 18, as against to 0.32% rise in the benchmark S&P BSE Sensex.
The company engaged in OTC and beverages business had reported 38% year on year (yoy) growth in net profit at Rs 4.1 crore for the quarter ended September 2014. Net sales grew 24% to Rs 40.88 crore on yoy basis.
Amrutanjan Health Care said the volume growth and pricing power has driven the top line improvement of OTC business. The OTC business accounts 92% of total turnover of the company.
“We foresee a need to increase brand investments to sustain growth”, it added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)